Over the last decade, multiple studies have shown that specific inhibitors of mTOR can inhibit liver cancer growth26 and that targeting AKT and mTOR is able to inhibit the proliferation of HCC cells30. This evidence concerns the gene AKT1 and hepatocellular carcinoma.